- Home
- SER
as 07-26-2024 4:00pm EST
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | HUNTSVILLE |
| Market Cap: | 60.3M | IPO Year: | 2018 |
| Target Price: | N/A | AVG Volume (30 days): | 20.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.25 | EPS Growth: | -11.83 |
| 52 Week Low/High: | $5.93 - $31.64 | Next Earning Date: | 05-14-2024 |
| Revenue: | $3,148,500 | Revenue Growth: | 410.71% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Serina Therapeutics Inc. Common Stock News
SER Breaking Stock News: Dive into SER Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation
GuruFocus.com
a month ago
A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
Energy Global
a month ago
ANDRITZ to equip new Silvan hydropower plant in Türkiye
USA TODAY
a month ago
Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
Business Wire
a month ago
Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
Business Wire
a month ago
Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
GlobeNewswire
a month ago
SEALSQ to Launch Two New Quantum Resistant Chips
Reuters
a month ago
Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll
Compare SER vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SER Serina Therapeutics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.